Prevalence and incidence of bronchiectasis in Catalonia, Spain: A population-based study

Respiratory Medicine

Volumn 121, Issue , 2016, Pages 26-31

  Monteagudo, Mònica ^a,b   Rodríguez Blanco, Teresa ^a,b   Barrecheguren, Miriam ^c   Simonet, Pere ^d   Miravitlles, Marc ^c  

^a Research Institute University Primary Care IDIAP Jordi Gol   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d INSTITUT CATALÀ DE LA SALUT   (Spain)

Author keywords

Bronchiectasis; Epidemiology; Exacerbations; Treatment

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; MUSCARINIC RECEPTOR BLOCKING AGENT; PHOSPHODIESTERASE IV INHIBITOR;

AGED; AGING; ARTICLE; BRONCHIECTASIS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DATA BASE; DISEASE EXACERBATION; FEMALE; GROUPS BY AGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX RATIO; SPAIN; SPIROMETRY; SPUTUM CULTURE; THORAX RADIOGRAPHY; ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; DRUG UTILIZATION; FACTUAL DATABASE; HEALTH CARE PLANNING; INFANT; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BRONCHIECTASIS; CHILD; CHILD, PRESCHOOL; COMORBIDITY; DATABASES, FACTUAL; DRUG UTILIZATION; FEMALE; HEALTH RESOURCES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREVALENCE; PRIMARY HEALTH CARE; SEX DISTRIBUTION; SPAIN; YOUNG ADULT;

EID: 84994339172     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2016.10.014     Document Type: Article

References (27)

1. [1] Barker, A.F., Bronchiectasis. N. Engl. J. Med. 346 (2012), 1383–1393.
2. [2] Seitz, A.E., Olivier, K.N., Adjemian, J., Holland, S.M., Prevot, D.R., Trends in bronchiectasis among medicare beneficiaries in the United States, 2000 to 2007. Chest 142 (2012), 432–439.
3. [3] Twiss, J., Metcalfe, R., Edwards, E., Byrnes, C., New Zealand national inicidence of bronchiectasis “too high” for a developed country. Arch. Dis. Child. 90 (2005), 737–740.
4. [4] Weycker, D., Edelsberg, J., Oster, G., Tino, G., Prevalence and economic burden of bronchiectasis. Clin. Pul. Med. 12 (2005), 205–209.
5. [5] Vendrell, M., de Gracia, J., Rodrigo, M.J., et al. Antibody production deficiency with normal IgG levels in bronchiectasis of unknown etiology. Chest 127 (2005), 197–204.
6. [6] Dagli, E., Non cystic fibrosis bronchiectasis. Paediatr. Respir. Rev. 1 (2000), 64–70.
7. [7] McDonnell, M.J., Ward, C., Lordan, J.L., Rutherford, R.M., Non-cystic fibrosis bronchiectasis. QJM 106 (2013), 709–715.
8. [8] Ringshausen, F.C., de Roux, A., Pletz, M.W., Hämäläinen, N., Welte, T., Rademacher, J., Bronchiectasis-associated hospitalizations in Germany, 2005-2011: a population-based study of disease burden and trends. PloS One, 8, 2013, e71109.
9. [9] Wilczynska, M.M., Condliffe, A.M., McKeon, D.J., Coexistence of bronchiectasis and rheumatoid arthritis: revisited. Respir. Care 58 (2013), 694–701.
10. [10] Seitz, A.E., Oliver, K.N., Steiner, C.A., Montes de Oca, R., Holland, S.M., Prevots, R., Trends and burden of bronchiectasis-associated hospitalizations in the United States, 1993-2006. Chest 138 (2010), 944–949.
11. [11] Kwak, H.J., Moon, J.Y., Choi, Y.W., et al. High prevalence of bronchiectasis in adults: analysis of CT findings in a Health screening program. Tohoku. J. Exp. Med. 222 (2010), 237–242.
12. [12] Information System for the Improvement of Research in Primary care, SIDIAP. accessed 08.02.2016 http://www.sidiap.org/index.php/es/component/content/article?id=33:base-de-dades.
13. [13] Barrecheguren, M., Monteagudo, M., Ferrer, J., et al. Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study. Respir. Med. 111 (2016), 47–53.
14. [14] McShane, P.J., Naureckas, E.T., Tino, G., Strek, M.E., Non-cystic fibrosis bronchiectasis. Am. J. Respir. Crit. Care. Med. 188 (2013), 647–656.
15. [15] Quint, J.K., Millett, E.R., Joshi M, M., et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study. Eur. Respir. J., 2015, 10.1183/13993003.01033-2015.
16. [16] Boyton, R.J., Bronchiectasis. Medicine 36 (2008), 315–320.
17. [17] Goeminne, P.C., Scheers, H., Decraene, A., Seys, S., Dupont, L.J., Risk factors for morbidity and death in non-cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients. Respir. Res., 13, 2012, 21.
18. [18] Ringshausen, F.C., de Roux, A., Diel, R., et al. Bronchiectasis in Germany: a population-based estimation of disease prevalence. Eur. Respir. J. 46 (2015), 1805–1807.
19. [19] Miravitlles, M., Molina, J., Quintano, J.A., Campuzano, A., Perez, J., Roncero, C., Factors associated with depression and severe depression in patients with COPD. Respir. Res. 108 (2014), 1615–1625.
20. [20] British Thoracic Society Bronchiectasis (non-CF) Guideline Group, Guideline for non-CF bronchiectasis. Thorax, 65, 2010, i1ei58, 10.1136/thx.2010.136119.
21. [21] Vendrell, M., de Gracia, J., Olveira, C., et al. Diagnosis and treatment of bronchiectasis, arch. Bronconeumol 44 (2008), 629–640.
22. [22] Finklea, J.D., Khan, G., Thomas, S., et al. Predictors of mortality in hospitalized patients with acute exacerbations of bronchiectasis. Respir. Med. 104 (2010), 816–821.
23. [23] de Souza, A., Brown, J.S., Loebinger, M.R., et al. Research priorities in bronchiectasis. Thorax 68 (2013), 695–696.
24. [24] Monteagudo, M., Rodriguez-Blanco, T., Parcet, J., et al. Variability in the performing of spirometry and its consequences in the treatment of COPD in primary care. Arch. Bronconeumol 47 (2010), 226–233.
25. [25] Martínez García, M.A., Máiz, C., Catalán P, P., Treatment of non-cystic fibrosis bronchiectasis, arch. Bronconeumol 47 (2011), 599–609.
26. [26] Martinez-Garcia, M.A., Soler-Cataluña, J.J., Perpiñá-Tordera, M., Román-Sánchez, P., Soriano, J., Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest 132 (2007), 1565–1572.
27. [27] Chalmers, J.D., Aliberti, S., Blasi, F., Mangement of bronchiectasis in adults. Eur. Respir. J. 45 (2015), 1446–1462.